Michael Oredsson: ‘What Makes Akkermansia Different from Other Probiotics’

Staff editor

11.10.2022

Michael Oredsson, CEO at The Akkermansia Company, discussed with the new postbiotic supplement containing pastorised Akkermansia muciniphila.

Michael Oredsson, CEO at The Akkermansia Company, discussed with Microbiomepost the new postbiotic supplement containing pastorised Akkermansia muciniphila.

Subscribe to MicrobiomePost newsletter

Take full advantage of MicrobiomePost‘s features.

Via Podgora 12/A, 20122, Milan, Italy – VAT: IT05299040963

Read MicrobiomePost’s Privacy Policy

This communication is only intended for business-to-business and health care professionals.
This communication is not intended for consumers of final consumer goods.
Nothing on this page is meant to be perceived as an approved claim.

Michael Oredsson: ‘What Makes Akkermansia Different from Other Probiotics’

Latest related content

Insights into Indigenous skin microbiotas offer clues to fungal infection

The microbiome and athletic performance: scientific insights and investment landscape

Engineering the gut: Endure Biotherapeutics secures NIH funding for groundbreaking FAP therapy

Mice study shows how gut bacteria help train immune cells to prevent inflammation

A $2.5 billion catalyst: how the Gates Foundation is redefining women’s health innovation—with the microbiome in the spotlight

Unravelling the secrets of protein glycosylation

Latest News